Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Bates

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|December 28, 2002
Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRGeorge Lin, Graham Simmons, Stefan Pöhlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2023
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent bindingMarcus J Bolton, Jefferson J S Santos, Claudia P Arevalo, et al.
Veterinary Microbiology|December 30, 2015
Ebola virus mediated infectivity is restricted in canine and feline cellsZiying Han, Stephen M Bart, Gordon Ruthel, et al.
Molecular Pharmacology|May 15, 2010
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cellsParag P Shah, Tianhua Wang, Rachel L Kaletsky, et al.
Journal of Virology|October 14, 2004
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirusAndrea Marzi, Thomas Gramberg, Graham Simmons, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Viruses|August 28, 2025
Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV GlycoproteinTomaz B Manzoni, Jonna B Westover, Kendall A Lundgreen, et al.
Nature Nanotechnology|June 26, 2023
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Mohamad-Gabriel Alameh, Kamila Butowska, et al.
Plos Pathogens|February 12, 2014
The major cellular sterol regulatory pathway is required for Andes virus infectionJosiah Petersen, Mary Jane Drake, Emily A Bruce, et al.
Proceedings. Mathematical, Physical, and Engineering Sciences|April 18, 2017
A restatement of the natural science evidence concerning catchment-based 'natural' flood management in the UKSimon J Dadson, Jim W Hall, Anna Murgatroyd, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|December 28, 2002
Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRGeorge Lin, Graham Simmons, Stefan Pöhlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2023
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent bindingMarcus J Bolton, Jefferson J S Santos, Claudia P Arevalo, et al.
Veterinary Microbiology|December 30, 2015
Ebola virus mediated infectivity is restricted in canine and feline cellsZiying Han, Stephen M Bart, Gordon Ruthel, et al.
Molecular Pharmacology|May 15, 2010
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cellsParag P Shah, Tianhua Wang, Rachel L Kaletsky, et al.
Journal of Virology|October 14, 2004
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirusAndrea Marzi, Thomas Gramberg, Graham Simmons, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Viruses|August 28, 2025
Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV GlycoproteinTomaz B Manzoni, Jonna B Westover, Kendall A Lundgreen, et al.
Nature Nanotechnology|June 26, 2023
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Mohamad-Gabriel Alameh, Kamila Butowska, et al.
Plos Pathogens|February 12, 2014
The major cellular sterol regulatory pathway is required for Andes virus infectionJosiah Petersen, Mary Jane Drake, Emily A Bruce, et al.
Proceedings. Mathematical, Physical, and Engineering Sciences|April 18, 2017
A restatement of the natural science evidence concerning catchment-based 'natural' flood management in the UKSimon J Dadson, Jim W Hall, Anna Murgatroyd, et al.
Pageof 9